For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

What is the main cause of myocardial infarction A cardiologist explains how atherosclerosis and blood clots trigger heart ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...

Confused about the difference between a myocardial infarction and a heart attack Read ahead as an expert explains the causes symptoms and why acting fast is crucial for your heart health ...

There is increased risk for incident myocardial infarction among adults aged 18 to 64 years with joint exposure to ozone and increased ambient temperature.

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

In an exclusive chat with Deccan Chronicle, Kshemavana’s Chief Wellness Officer warns against drug abuse, nutraceutical ...

Mount Nittany Health Emergency Medical Services has been honored with the American Heart Association’s 2025 Mission: Lifeline ...

For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...